Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01572506 · ClinicalTrials.gov registry record · Phase 1
Mechanisms Accounting for Unexplained Anemia in the Elderly
A Phase 1 study, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- Phase 1
- Development phase
- 58
- Enrollment target
NCT01572506 is a Phase 1 study that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 58 participants.
The verdict
NCT01572506, a Phase 1 study, has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 58 participants
- Enrollment target
Study Summary
Background: \- Anemia occurs commonly and is associated with poor outcomes in the elderly. In about a third of anemia cases in older people (over age 65), the cause of anemia is unexplained. Anemia in older adults may be caused by the bone marrow's inability to produce red blood cells fast enough to replace older red blood cells that have died. Researchers want to look at unexplained anemia by studying the life span of red blood cells in younger adults and older adults. To do so, a vitamin called Biotin will be used as a marker on the red blood cells. Objectives: \- To investigate possible causes of unexplained anemia in older people. Eligibility: * Individuals in the following groups: * Men and women between 18 and 50 years of age who do not have anemia * Men and women at least 70 years of age who do not have anemia. * Men and women at least 70 years of age who have iron-deficiency anemia. * Men and women at least 70 years of age who have anemia with no known cause. Design: * Participants will be screened with a physical exam and medical history. Blood and urine samples will be collected. * Participants will have an overnight stay for the first study visit. They will provide a blood sample to which Biotin will be added. The blood sample with Biotin will then be returned to the participant. Twenty-four hours later, another blood sample will be collected. * Participants will have up to 14 additional study visits. At each visit, blood samples will be collected to measure the amount of Biotin remaining in the blood. * Participants may also provide a separate blood sample for genetic testing. These tests may provide more information about genetic causes of unexplained anemia.
Interventions
- DRUG Biotin RBC survival
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2012-03-29 |
| Est. Completion | 2015-07-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01572506
The ClinicalTrials.gov registry entry for NCT01572506 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biotin RBC survival is the first listed.
NCT01572506 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01572506 about?
NCT01572506 is a clinical study titled "Mechanisms Accounting for Unexplained Anemia in the Elderly". Background: \- Anemia occurs commonly and is associated with poor outcomes in the elderly. In about a third of anemia cases in older people (over age 65), the cause of anemia is unexplained. Anemia in older adults may be caused by the bone marrow's inability to produce red blood cells fast enough t...
What is the current status of trial NCT01572506?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 58 participants. The study started on 2012-03-29. Estimated completion is 2015-07-30.
What interventions are being tested in trial NCT01572506?
The interventions under investigation include: Biotin RBC survival (DRUG).
Who is sponsoring clinical trial NCT01572506?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.